Rocket Pharmaceuticals

Filed a patent for "plakophilin-2 (pkp2) gene therapy using aav vector" on Fri, January 6, 2023

Filed a patent for "plakophilin-2 (pkp2) gene therapy using aav vector" on Wed, April 19, 2023

Filed a patent for "plakophilin-2 (pkp2) gene therapy using aav vector" on Fri, July 7, 2023

Filed a patent for "engineered parkin and uses thereof" on Thu, June 8, 2023

Filed a patent for "gene therapy vector for eef1a2 and uses thereof" on Thu, October 19, 2023

Filed a patent for "csrp3 (cysteine and glycine rich protein 3) gene therapy" on Thu, August 17, 2023

Filed a patent for "adeno-associated viral vector for glut1 expression and uses thereof" on Thu, August 31, 2023

Filed a patent for "treatment of danon disease" on Thu, February 1, 2024

Filed a patent for "b-cell lymphoma 2-associated anthanogene 3 (bag3) gene therapy using aav vector" on Fri, April 22, 2022